Pre-pregnancy serum complement C3 level is a predictor of preterm birth for pregnancies with systemic lupus erythematosus.
Preconception care
Pregnancy
Preterm birth
Serum complement 3 level
Systemic lupus erythematosus
Journal
Arthritis research & therapy
ISSN: 1478-6362
Titre abrégé: Arthritis Res Ther
Pays: England
ID NLM: 101154438
Informations de publication
Date de publication:
12 05 2021
12 05 2021
Historique:
received:
15
03
2021
accepted:
26
04
2021
entrez:
13
5
2021
pubmed:
14
5
2021
medline:
22
6
2021
Statut:
epublish
Résumé
This study aimed to clarify predictors of preterm birth in pregnancy of women with systemic lupus erythematosus (SLE). We investigated the predictors of preterm birth before pregnancy from the perspective of the importance of preconception care. We analysed fetal outcomes of 108 pregnancies in 74 SLE patients in a retrospective study. We compared pre-pregnancy clinical characteristics and disease activity in these women between the preterm birth and full-term birth groups to select predictive factors for preterm birth before pregnancy. Eighty-three of 108 pregnancies resulted in live births, of which 27 (25.0%) were preterm births. Pre-pregnancy serum complement 3 (C3) level was significantly lower in the preterm birth group (77.0 mg/dl) than the full-term birth group (87.5 mg/dl) (P = 0.029). Multivariate analysis identified history of lupus nephritis (odds ratio: 5.734, 95% CI 1.568-21.010, P = 0.008) and low C3 level (< 85 mg/dl) at pre-pregnancy (odds ratio 4.498, 95% CI 1.296-15.616, P = 0.018) as risk factors for preterm birth. The greater the number of these risk factors, the higher was the preterm birth rate (P = 0.0007). In the case of SLEDAI score ≤ 4, the preterm birth rate was higher in the pre-pregnancy low C3 group (< 85 mg/dl) (42.1%) than in the high C3 group (C3 ≥ 85 mg/dl) (14.7%) (P = 0.018). For patients with a history of LN, treatment management focusing on pre-pregnancy serum complement levels is very important.
Sections du résumé
BACKGROUND
This study aimed to clarify predictors of preterm birth in pregnancy of women with systemic lupus erythematosus (SLE). We investigated the predictors of preterm birth before pregnancy from the perspective of the importance of preconception care.
METHODS
We analysed fetal outcomes of 108 pregnancies in 74 SLE patients in a retrospective study. We compared pre-pregnancy clinical characteristics and disease activity in these women between the preterm birth and full-term birth groups to select predictive factors for preterm birth before pregnancy.
RESULTS
Eighty-three of 108 pregnancies resulted in live births, of which 27 (25.0%) were preterm births. Pre-pregnancy serum complement 3 (C3) level was significantly lower in the preterm birth group (77.0 mg/dl) than the full-term birth group (87.5 mg/dl) (P = 0.029). Multivariate analysis identified history of lupus nephritis (odds ratio: 5.734, 95% CI 1.568-21.010, P = 0.008) and low C3 level (< 85 mg/dl) at pre-pregnancy (odds ratio 4.498, 95% CI 1.296-15.616, P = 0.018) as risk factors for preterm birth. The greater the number of these risk factors, the higher was the preterm birth rate (P = 0.0007). In the case of SLEDAI score ≤ 4, the preterm birth rate was higher in the pre-pregnancy low C3 group (< 85 mg/dl) (42.1%) than in the high C3 group (C3 ≥ 85 mg/dl) (14.7%) (P = 0.018).
CONCLUSION
For patients with a history of LN, treatment management focusing on pre-pregnancy serum complement levels is very important.
Identifiants
pubmed: 33980284
doi: 10.1186/s13075-021-02522-x
pii: 10.1186/s13075-021-02522-x
pmc: PMC8114516
doi:
Substances chimiques
Complement C3
0
Complement C4
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
140Références
Am J Obstet Gynecol. 2008 Aug;199(2):127.e1-6
pubmed: 18456233
Clin Exp Immunol. 1997 Jan;107(1):83-8
pubmed: 9010261
Arthritis Rheum. 1981 Apr;24(4):592-601
pubmed: 7213441
Ann Intern Med. 2015 Aug 4;163(3):153-63
pubmed: 26098843
Clin J Am Soc Nephrol. 2010 Nov;5(11):2060-8
pubmed: 20688887
Arthritis Rheum. 1997 Sep;40(9):1725
pubmed: 9324032
Ann Rheum Dis. 2013 Sep 1;72(9):1536-9
pubmed: 23361085
J Rheumatol. 2011 Jun;38(6):1012-6
pubmed: 21406496
Lupus. 1998;7(9):635-8
pubmed: 9884102
Minerva Ginecol. 2018 Feb;70(1):99-119
pubmed: 28895680
Arch Dis Child Fetal Neonatal Ed. 2003 Mar;88(2):F101-5
pubmed: 12598496
Lancet. 2008 Jan 5;371(9606):75-84
pubmed: 18177778
N Engl J Med. 2005 Dec 15;353(24):2550-8
pubmed: 16354891
Lupus. 2019 Nov;28(13):1503-1509
pubmed: 31623520
Rheumatology (Oxford). 1999 Jun;38(6):559-63
pubmed: 10402078
Int J Rheum Dis. 2019 Mar;22(3):425-433
pubmed: 30398013
Ann Rheum Dis. 2017 Mar;76(3):476-485
pubmed: 27457513
Rheumatology (Oxford). 2018 Oct 1;57(10):1707-1720
pubmed: 29165607